Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload

[1]  S. Davies,et al.  Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. , 2001, Journal of the American Society of Nephrology : JASN.

[2]  S. Davies.  Monitoring of Long-Term Peritoneal Membrane Function , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[3]  Bengt Rippe,et al.  Evaluation and Management of Ultrafiltration Problems in Peritoneal Dialysis , 2000 .

[4]  A. Donker,et al.  Assessment of the Effectiveness, Safety, and Biocompatibility of Icodextrin in Automated Peritoneal Dialysis , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[5]  R. Selgas,et al.  Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[6]  A. Cueto-Manzano,et al.  Is high peritoneal transport rate an independent risk factor for CAPD mortality? , 2000, Kidney international.

[7]  T. Tsai,et al.  Impact of peritoneal membrane transport on technique failure and patient survival in a population on automated peritoneal dialysis. , 1999, ASAIO journal.

[8]  J. Messana,et al.  Methicillin Resistance Patterns Associated with Peritonitis in a University-Based Peritoneal Dialysis Center a , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[9]  G. Woodrow,et al.  Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  G. Coles.  Biocompatibility and New Fluids , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[11]  B. Piraino,et al.  Small-solute clearances in diabetic subjects on continuous ambulatory peritoneal dialysis: comparison to nondiabetic subjects. , 1999, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[12]  A. Donker,et al.  Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  D. Churchill,et al.  Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. , 1998, Journal of the American Society of Nephrology : JASN.

[14]  A. Donker,et al.  Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  M. Wilkie,et al.  Icodextrin 7.5% Dialysate Solution (Glucose Polymer) in Patients with Ultrafiltration Failure: Extension of Capd Technique Survival , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[16]  R. Krediet,et al.  Icodextrin'S Effects on Peritoneal Transport , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[17]  N. Schouten,et al.  Peritoneal transport characteristics with glucose polymer based dialysate. , 1996, Kidney international.

[18]  D. Oreopoulos,et al.  Biocompatibility of peritoneal dialysis solutions. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  A. Scrimgeour,et al.  Cost-Containment in CAPD Patients with Ultrafiltration Failure , 1995 .

[20]  M. Raftery,et al.  A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. , 1994, Kidney international.

[21]  D. Struijk,et al.  Ultrafiltration Failure in Continuous Ambulatory Peritoneal Dialysis , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[22]  C. Brown,et al.  The effect of glucose polymers on water removal and protein clearances during CAPD. , 1993, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[23]  J. Waniewski,et al.  Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. , 1990, Kidney international.

[24]  C. Kjellstrand,et al.  Mortality on dialysis--on the influence of early start, patient characteristics, and transplantation and acceptance rates. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  Twardowski Zj.  PET--a simpler approach for determining prescriptions for adequate dialysis therapy. , 1990 .

[26]  Z. Twardowski.  PET--a simpler approach for determining prescriptions for adequate dialysis therapy. , 1990, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.